IndietroPulmonary Embolism: Disorders of Pulmonary Circulation
Guida di studio - Note intelligenti
Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.
Pulmonary Embolism and Disorders of Pulmonary Circulation
Introduction
Pulmonary embolism (PE) is a critical disorder of pulmonary circulation characterized by the obstruction of blood flow within the pulmonary arteries. This condition can range from asymptomatic presentations to sudden death, depending on the size and location of the embolus and the patient's underlying cardiopulmonary status.
Types of Emboli
Thrombotic Embolism: Most common type; originates outside the pulmonary circulation, typically from deep vein thrombosis (DVT) in the lower extremities (popliteal, femoral, iliac veins). Upper extremity thrombi are less common.
Fat Embolism: Often associated with long bone fractures.
Air Embolism: Entry of air into the circulation, e.g., during trauma or medical procedures.
Amniotic Fluid Embolism: Occurs when amniotic fluid enters maternal circulation, typically during labor.
Risk Factors for Thromboembolism
Risk factors for PE are classified into three main categories:
Risk | Examples |
|---|---|
Venous stasis | Bed-ridden/prolonged hospitalization or nursing home, paralysis/spinal cord injury, lengthy travel (> 4 hours) |
Hypercoagulable states | Genetic mutations (Factor V Leiden, prothrombin mutations, protein C and S deficiency), family history, active cancer, estrogen therapy, obesity, pregnancy, antiphospholipid syndrome |
Vascular damage | Trauma, surgery (especially orthopedic), central venous catheter placement |
Pathophysiology of Pulmonary Embolism
PE leads to a cascade of physiological changes affecting hemodynamics, gas exchange, and the work of breathing:
Hemodynamics:
Increased pulmonary vascular resistance due to vascular obstruction and vasoconstriction (mediated by thromboxane A2 and serotonin).
Gas Exchange:
Hypoxemia (): Caused by perfusion of low V/Q units and decreased cardiac output.
Alveolar Dead Space: Vascular obstruction leads to perfusion of high V/Q units (ventilated but not perfused alveoli).
Work of Breathing:
Decreased lung compliance due to reduced surfactant production, edema, and alveolar hemorrhage.
Increased airway resistance from reflex bronchoconstriction.
Tachypnea due to stimulation of irritant receptors and response to hypoxia.
Ventilation/Perfusion (V/Q) Mismatch in PE
PE causes a mismatch between ventilation and perfusion:
Low V/Q: Vasoconstricted units lose perfusion, leading to decreased surfactant production and alveolar collapse.
High V/Q (Dead Space): Ventilation of blocked/vasoconstricted units results in dead space ventilation.
Compensation: Pulmonary arterial pressure (PAP) increases to redirect blood flow to normal units.
Clinical Presentation
Typical Presentation
Respiratory Symptoms:
Sudden onset dyspnea
Bronchoconstriction (wheezing)
Crackles on lung auscultation
Tachypnea (rapid breathing)
Pleuritic chest pain due to alveolar hemorrhage
Hemoptysis (coughing up blood)
Hemodynamic Symptoms:
Acute pulmonary artery pressure increase (pulmonary hypertension)
Low cardiac output (CO) with large emboli
Near-syncope or syncope
Tachycardia
Hypoxemia:
V/Q mismatch
Low
Lactic acidosis
Evidence of DVT:
Present in about 70% of cases
Positive D-dimer (lab test for fibrin degradation)
Massive Pulmonary Embolism
Significant or absolute loss of cardiac output (CO)
Sudden collapse or death
Low blood pressure (shock)
Loss of consciousness
Crushing substernal chest pain
Rapid, weak pulse
Cyanosis
Jugular venous congestion (JVD)
Diagnosis of Pulmonary Embolism
Clinical Suspicion: Only ~20% of suspected cases are confirmed.
Low Risk of PE:
D-dimer test (high sensitivity, low specificity) to rule out PE.
High Risk of PE:
Pulmonary imaging required.
Imaging Modalities
CT Pulmonary Angiography (CTPA):
First-line imaging modality.
Requires contrast medium injection.
Contraindicated in patients with significant renal insufficiency or allergy.
Ventilation/Perfusion (V/Q) Scan:
Uses inhaled and injected radioisotopes to assess perfusion abnormalities.
Treatment of Pulmonary Embolism
Hemodynamically Stable Patients:
Anticoagulation therapy:
Warfarin
Heparin (IV only; used as initial or bridge therapy)
Low Molecular Weight Heparins (e.g., Enoxaparin)
Factor Xa inhibitors (e.g., Rivaroxaban, Apixaban)
Hemodynamically Unstable Patients (SBP < 90 mmHg):
Thrombolysis followed by anticoagulation
Alteplase (tissue plasminogen activator) to degrade fibrin clot
Key Terms and Definitions
Pulmonary Embolism (PE): Obstruction of pulmonary arteries by emboli, most commonly thrombotic.
Deep Vein Thrombosis (DVT): Formation of blood clots in deep veins, usually of the lower extremities.
Ventilation/Perfusion (V/Q) Ratio: The ratio of air reaching the alveoli to blood reaching the alveoli; normal is approximately 0.8.
D-dimer: A fibrin degradation product used as a marker for thrombotic activity.
Hemoptysis: Coughing up blood, often due to alveolar hemorrhage.
Jugular Venous Distension (JVD): Visible bulging of the jugular vein, indicating increased central venous pressure.
Example: V/Q Mismatch Equation
The V/Q ratio is a key concept in understanding gas exchange abnormalities in PE:
Normal V/Q ratio:
In PE, areas of the lung may have:
Low V/Q (poor perfusion)
High V/Q (dead space ventilation)
Summary Table: Pathophysiological Effects of PE
System | Effect |
|---|---|
Hemodynamics | ↑ Pulmonary vascular resistance, vasoconstriction |
Gas Exchange | ↓ PaO₂ (hypoxemia), ↑ alveolar dead space |
Work of Breathing | ↓ Lung compliance, ↑ airway resistance, tachypnea |
Additional info: The notes have been expanded to include definitions, equations, and clinical context for a comprehensive understanding suitable for Anatomy & Physiology students.